[Federal Register Volume 65, Number 234 (Tuesday, December 5, 2000)]
[Notices]
[Page 75959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30940]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 15, 2000, Knoll 
Pharmaceutical Company, 30 North Jefferson Road, Whippany, New Jersey 
07981, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than February 5, 2001.

    Dated: November 20, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-30940 Filed 12-4-00; 8:45 am]
BILLING CODE 4410-09-M